Michael Vogelbaum MD, PhD
Michael Vogelbaum MD, PhD
Bestätigte E-Mail-Adresse bei
Zitiert von
Zitiert von
Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group
PY Wen, DR Macdonald, DA Reardon, TF Cloughesy, AG Sorensen, ...
Journal of clinical oncology 28 (11), 1963-1972, 2010
A randomized trial of bevacizumab for newly diagnosed glioblastoma
MR Gilbert, JJ Dignam, TS Armstrong, JS Wefel, DT Blumenthal, ...
New England Journal of Medicine 370 (8), 699-708, 2014
Response assessment criteria for brain metastases: proposal from the RANO group
NU Lin, EQ Lee, H Aoyama, IJ Barani, DP Barboriak, BG Baumert, ...
The lancet oncology 16 (6), e270-e278, 2015
Response Assessment in Neuro-Oncology working group and European Association for Neuro-Oncology recommendations for the clinical use of PET imaging in gliomas
NL Albert, M Weller, B Suchorska, N Galldiks, R Soffietti, MM Kim, ...
Neuro-oncology 18 (9), 1199-1208, 2016
Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review
L Rogers, I Barani, M Chamberlain, TJ Kaley, M McDermott, J Raizer, ...
Journal of neurosurgery 122 (1), 4-23, 2015
Radiotherapeutic and surgical management for newly diagnosed brain metastasis (es): An American Society for Radiation Oncology evidence-based guideline
MN Tsao, D Rades, A Wirth, SS Lo, BL Danielson, LE Gaspar, ...
Practical radiation oncology 2 (3), 210-225, 2012
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
BM Ellingson, M Bendszus, J Boxerman, D Barboriak, BJ Erickson, ...
Neuro-oncology 17 (9), 1188-1198, 2015
Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas
MJ van den Bent, JS Wefel, D Schiff, MJB Taphoorn, K Jaeckle, L Junck, ...
The lancet oncology 12 (6), 583-593, 2011
Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma
S Kunwar, S Chang, M Westphal, M Vogelbaum, J Sampson, G Barnett, ...
Neuro-oncology 12 (8), 871-881, 2010
Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells
SO Rahaman, PC Harbor, O Chernova, GH Barnett, MA Vogelbaum, ...
Oncogene 21 (55), 8404-8413, 2002
Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma
MM Grabowski, PF Recinos, AS Nowacki, JL Schroeder, L Angelov, ...
Journal of neurosurgery 121 (5), 1115-1123, 2014
Serum S100β: A noninvasive marker of blood‐brain barrier function and brain lesions
AA Kanner, N Marchi, V Fazio, MR Mayberg, MT Koltz, V Siomin, ...
Cancer: Interdisciplinary International Journal of the American Cancer …, 2003
Response assessment in neuro-oncology clinical trials
PY Wen, SM Chang, MJ Van den Bent, MA Vogelbaum, DR Macdonald, ...
Journal of Clinical Oncology 35 (21), 2439-2449, 2017
Myeloid-derived suppressor cell accumulation and function in patients with newly diagnosed glioblastoma
B Raychaudhuri, P Rayman, J Ireland, J Ko, B Rini, EC Borden, J Garcia, ...
Neuro-oncology 13 (6), 591-599, 2011
Treatment for brain metastases: ASCO-SNO-ASTRO guideline
MA Vogelbaum, PD Brown, H Messersmith, PK Brastianos, S Burri, ...
Neuro-oncology 24 (3), 331-357, 2022
Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3 …
MJ van den Bent, B Baumert, SC Erridge, MA Vogelbaum, AK Nowak, ...
The Lancet 390 (10103), 1645-1653, 2017
Poor drug distribution as a possible explanation for the results of the PRECISE trial
JH Sampson, G Archer, C Pedain, E Wembacher-Schröder, M Westphal, ...
Journal of neurosurgery 113 (2), 301-309, 2010
End point assessment in gliomas: novel treatments limit usefulness of classical Macdonald's Criteria
MJ van den Bent, MA Vogelbaum, PY Wen, DR Macdonald, SM Chang
Journal of Clinical Oncology 27 (18), 2905-2908, 2009
Local control of brain metastases by stereotactic radiosurgery in relation to dose to the tumor margin
MA Vogelbaum, L Angelov, SY Lee, L Li, GH Barnett, JH Suh
Journal of neurosurgery 104 (6), 907-912, 2006
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539
L Rogers, P Zhang, MA Vogelbaum, A Perry, LS Ashby, JM Modi, ...
Journal of neurosurgery 129 (1), 35-47, 2017
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20